Literature DB >> 20831913

Rabies vaccines: WHO position paper--recommendations.

.   

Abstract

This article presents the WHO recommendations on the use of rabies vaccines excerpted from the recently published Rabies vaccines: WHO position paper. This document replaces the WHO position paper entitled Rabies vaccines WHO position paper published in the Weekly Epidemiological Record in December 2007. Footnotes to this paper provide a limited number of core references; their abstracts as well as a more comprehensive list of references may be found at http://www.who.int/immunization/documents/positionpapers/en/index.html. Grading tables which assess the quality of scientific evidence for key conclusions are also available through this link and are referenced in the position paper. In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and combinations of vaccines against diseases that have an international public health impact. These papers are concerned primarily with the use of vaccines in large-scale immunization programmes; they summarize essential background information on diseases and vaccines, and conclude with WHO's current position on the use of vaccines in the global context. This updated paper reflects the recent recommendations of WHO's Strategic Advisory Group of Experts on immunization, or SAGE.
Copyright © 2010. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20831913     DOI: 10.1016/j.vaccine.2010.08.082

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  35 in total

1.  Effect of Corticosteroids on RVNA production of a patient with acute disseminated encephalomyelitis following rabies vaccination as well as administration of HRIG.

Authors:  Jun Peng; Li Chen; Zheng-Gang Zhu; Ze-Rong Zhu; Quan Hu; Yuan Fang
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

2.  Targeting Vaccine-Induced Extrafollicular Pathway of B Cell Differentiation Improves Rabies Postexposure Prophylaxis.

Authors:  Shannon L Haley; Evgeni P Tzvetkov; Samantha Meuwissen; Joseph R Plummer; James P McGettigan
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

3.  APRIL:TACI axis is dispensable for the immune response to rabies vaccination.

Authors:  Shannon L Haley; Evgeni P Tzvetkov; Andrew G Lytle; Kishore R Alugupalli; Joseph R Plummer; James P McGettigan
Journal:  Antiviral Res       Date:  2017-06-12       Impact factor: 5.970

4.  Immunogenicity and safety of purified vero cell rabies vaccine (PVRV) produced by Liaoning Cheng Da Co. under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese adults aged 50 and above.

Authors:  Jing Wang; FengJi Luo; ZiJian Feng; Li Li; YunHua Bai; Xing Ai; JianXin Ma; Zheng Zhang; NianMin Shi
Journal:  Hum Vaccin Immunother       Date:  2017-01-02       Impact factor: 3.452

Review 5.  Zagreb regimen, an abbreviated intramuscular schedule for rabies vaccination.

Authors:  Jiangping Ren; Linong Yao; Jimin Sun; Zhenyu Gong
Journal:  Clin Vaccine Immunol       Date:  2014-11-12

6.  Immunogenicity and safety of purified chick-embryo cell rabies vaccine under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese children 6 to 17 years old and adults over 50 years: a randomized open-label study.

Authors:  RongCheng Li; YanPing Li; ShuQing Wen; HuiChun Wen; Yi Nong; Zhaojun Mo; Fang Xie; Michele Pellegrini
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

7.  Making rabies prophylaxis more economical: immunogenicity and safety results from a preliminary study using a 2-1 intramuscular regimen in healthy volunteers.

Authors:  Guihua Huang; Huazhang Liu; Qing Tang; Pengcheng Yu; Xinxin Shen; Yibin Zhang; Xiangyi Liu; Qing Cao; Chuanxi Fu; Beiyan Liu; Ming Wang
Journal:  Hum Vaccin Immunother       Date:  2013-09-05       Impact factor: 3.452

8.  Validation of the rapid fluorescent focus inhibition test for rabies virus-neutralizing antibodies in clinical samples.

Authors:  Stefan Kostense; Susan Moore; Arjen Companjen; Alexander B H Bakker; Wilfred E Marissen; Rie von Eyben; Gerrit Jan Weverling; Cathleen Hanlon; Jaap Goudsmit
Journal:  Antimicrob Agents Chemother       Date:  2012-04-30       Impact factor: 5.191

9.  Post-exposure rabies prophylaxis in humans exposed to animals in Lublin province (Eastern Poland) in 2012-2015 - A retrospective study.

Authors:  Joanna Krzowska-Firych; Krzysztof Tomasiewicz; Agata Kozøowska
Journal:  Hum Vaccin Immunother       Date:  2017-02-06       Impact factor: 3.452

Review 10.  Intradermal vaccination for infants and children.

Authors:  Akihiko Saitoh; Yuta Aizawa
Journal:  Hum Vaccin Immunother       Date:  2016-05-02       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.